🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "targeted action to tackle cost of living challenges" in the upcoming Budget.

During an interview with media outlets, she noted that curbing price rises is a joint task of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven developed nations this year and next.

Possible Energy Cost Interventions

Reports indicate the administration could take action to reduce utility costs, for instance by cutting the current 5% rate of value-added tax charged on energy supplies.

A further possibility is to reduce some of the government charges currently included in bills.

Fiscal Limitations and Expert Predictions

The government will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for such actions.

The view from the majority of experts is that the Chancellor will have to introduce tax rises or budget cuts in order to adhere to her self-imposed borrowing rules.

Previously on the same day, calculations suggested there was a £22 billion gap for the chancellor to resolve, which is at the more modest range of projections.

"It is a shared task between the Bank of England and the government to bear down further on some of the causes of inflation," Reeves stated to the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and Global Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the most recent information from the OBR had not changed her pledge to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain world" with rising international and commercial concerns for the fiscal tax moves, probably to be focused on those "wealthiest."

Global Economic Tensions

Commenting on worries about the United Kingdom's trade ties with China she said: "The UK's security interests always take priority."

Recent announcement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader the US President to threaten an further 100% import tax on imports from the Asian country, increasing the possibility of an full-scale trade war between the two largest economies.

The American finance chief called the Chinese move "commercial pressure" and "a global supply chain power grab."

Questioned on considering the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the world economy and causes further challenges."

"It is my opinion there are sectors where we must challenge China, but there are also important prospects to export to China's economy, including financial services and other sectors of the economy. We've got to achieve that equilibrium appropriate."

The Treasury chief also stated she was working with G7 counterparts "on our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also recognized that the price the National Health Service pays for pharmaceuticals could go up as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global drug companies have said in recent statements that they are either halting or canceling operations in the United Kingdom, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the NHS spends on drugs would have to rise to stop firms and drug research funding leaving the United Kingdom.

Reeves informed the BBC: "We have seen as a result of the pricing regime, that drug testing, innovative medicines have not been provided in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to make sure that patients receiving treatment from the NHS are able to access the best life-saving medicines in the globe. And so we are examining all of that, and... aiming to secure more investment into Britain."